NetScientific (NSCI)

Sector:

Financials

104.00p
   
  • Change Today:
    -3.00p
  • 52 Week High: 180.00
  • 52 Week Low: 43.00
  • Currency: UK Pounds
  • Shares Issued: 20.98m
  • Volume: 30,298
  • Market Cap: £21.81m
  • RiskGrade: 410
  • Beta: 1.38

NetScientific's ProAxsis appoints North American distributor

By Josh White

Date: Thursday 19 Nov 2020

LONDON (ShareCast) - (Sharecast News) - Life sciences, technology investment and commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has appointed DiaPharma Group as the exclusive distributor of its portfolio of respiratory research assays for the key North America region.
The AIM-traded firm said DiaPharma, based in Ohio, specialised in the commercialisation of products within the research and diagnostic fields in the United States and Canada, and had done so since it was founded in 1997.

It said the partnership agreement provided DiaPharma with exclusive access to ProAxsis' activity-based immunoassay kits for the quantification of the active forms of neutrophil elastase, proteinase 3 and cathepsin G.

"We're delighted to have reached this agreement with DiaPharma," said ProAxsis chief executive officer Dr David Ribeiro.

"Finding a suitable commercial partner for our portfolio in North America was a key short-term objective for the company and we are very excited about partnering with a company that has such experience in the commercialisation of research-focused products in this region of substantial commercialisation potential."

John Clarkson, chairman of NetScientific, said that following the acquisition of all outside shareholdings, the appointment was "another significant step" in the continued planned business growth of ProAxsis and accelerating its progress into international markets.

"ProAxsis has made strong progress this year and this latest announcement illustrates the increased potential for its respiratory diagnostics offering in a post Covid-19 world.

"This also reinforces NetScientific's strategy of expanding cross-Atlantic bridges for our portfolio companies."

At 1520 GMT, shares in NetScientific were flat at 48p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

NetScientific Market Data

Currency UK Pounds
Share Price 104.00p
Change Today -3.00p
% Change -2.80 %
52 Week High 180.00
52 Week Low 43.00
Volume 30,298
Shares Issued 20.98m
Market Cap £21.81m
Beta 1.38
RiskGrade 410

NetScientific Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.62% below the market average32.62% below the market average32.62% below the market average32.62% below the market average32.62% below the market average
34.38% below the sector average34.38% below the sector average34.38% below the sector average34.38% below the sector average34.38% below the sector average
Price Trend
39.92% above the market average39.92% above the market average39.92% above the market average39.92% above the market average39.92% above the market average
40.15% above the sector average40.15% above the sector average40.15% above the sector average40.15% above the sector average40.15% above the sector average
Income Not Available
Growth
23.89% above the market average23.89% above the market average23.89% above the market average23.89% above the market average23.89% above the market average
23.33% above the sector average23.33% above the sector average23.33% above the sector average23.33% above the sector average23.33% above the sector average

NetScientific Dividends

No dividends found

Trades for 07-Dec-2021

Time Volume / Share Price
16:13 550 @ 103.15p
16:12 1,345 @ 104.78p
16:12 475 @ 104.00p
16:11 475 @ 104.00p
15:13 2,000 @ 105.00p

NetScientific Key Personnel

CEO Ilian Iliev
CFO Stephen Crowe

Top of Page